Head to Head Review: Teladoc (TDOC) versus iKang Healthcare Group (KANG)

Teladoc (NYSE: TDOC) and iKang Healthcare Group (NASDAQ:KANG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for Teladoc and iKang Healthcare Group, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc 0 4 12 0 2.75
iKang Healthcare Group 0 0 0 0 N/A

Teladoc currently has a consensus target price of $41.93, suggesting a potential downside of 1.92%. Given Teladoc’s higher possible upside, equities analysts clearly believe Teladoc is more favorable than iKang Healthcare Group.

Insider & Institutional Ownership

33.5% of iKang Healthcare Group shares are owned by institutional investors. 4.5% of Teladoc shares are owned by insiders. Comparatively, 30.2% of iKang Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

Teladoc has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, iKang Healthcare Group has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500.

Valuation and Earnings

This table compares Teladoc and iKang Healthcare Group’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teladoc $233.28 million 11.31 -$106.78 million ($1.65) -25.91
iKang Healthcare Group $435.71 million 3.19 -$11.25 million N/A N/A

iKang Healthcare Group has higher revenue and earnings than Teladoc.

Profitability

This table compares Teladoc and iKang Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Teladoc -45.77% -20.95% -13.11%
iKang Healthcare Group 3.16% 4.97% 2.30%

Summary

iKang Healthcare Group beats Teladoc on 8 of the 12 factors compared between the two stocks.

Teladoc Company Profile

Teladoc, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. Teladoc, Inc. was founded in 2002 and is headquartered in Purchase, New York.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc., together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items. The company also provides value-added services at selected medical centers, such as disease screening focusing on cancer screening, cardiovascular and chronic disease screening, and functional medicine testing; dental care comprising oral health, pediatric and cosmetic dentistry, orthodontics, and dental implants; outpatient services, which consists of acupuncture, Chinese medicine, gynecology, internal medicine, obstetrics, ophthalmology, pediatrics, urology, and minor surgery; and on-site healthcare management or clinical services. It primarily serves corporate and individual customers through a network of self-owned medical centers and the facilities of third-party service providers. As of July 28, 2017, it owned and operated a network of 108 self-owned medical centers in 33 cities of China, including Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Wuhan, Changsha, Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi'an, Wuhu, Guiyang, Ningbo, Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili, Mianyang, and Hong Kong. The company was formerly known as China iKang Healthcare, Inc. and changed its name to iKang Healthcare Group, Inc. in February 2014. iKang Healthcare Group, Inc. is headquartered in Beijing, the People's Republic of China.

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Middlefield Banc  Given Consensus Recommendation of “Strong Buy” by Brokerages
Zacks: Middlefield Banc Given Consensus Recommendation of “Strong Buy” by Brokerages
Starwood Property Trust  Given Consensus Recommendation of “Buy” by Brokerages
Starwood Property Trust Given Consensus Recommendation of “Buy” by Brokerages
Dai  Achieves Market Capitalization of $36.36 Million
Dai Achieves Market Capitalization of $36.36 Million
Tattoocoin   Achieves Market Cap of $476,659.00
Tattoocoin Achieves Market Cap of $476,659.00
EMCORE Co.  Given Average Rating of “Hold” by Brokerages
EMCORE Co. Given Average Rating of “Hold” by Brokerages
P.F. Chang's China Bistro  Bonds Trading 1.5% Lower
P.F. Chang's China Bistro Bonds Trading 1.5% Lower


© 2006-2018 Ticker Report. Google+.